Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Rhoshan Pharmaceuticals, Inc. See All Filings	D/A	2026-07-22 09:11:03 UTC
Amount To Be Raised $3,158,776 Associated Brokers / Dealers N/A CIK Number 0001756479 Filed Document 0001756479-26-000003 Exclusions or Exemptions 506b Accepted Date 2026-07-22 09:11:03 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
Rhoshan Pharmaceuticals, Inc. See All Filings	D/A	2024-09-11 13:57:39 UTC
Amount To Be Raised $1,758,793 Associated Brokers / Dealers N/A CIK Number 0001756479 Filed Document 0001756479-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-09-11 13:57:39 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
Rhoshan Pharmaceuticals, Inc. See All Filings	D	2023-09-22 10:32:04 UTC
Amount To Be Raised $758,800 Associated Brokers / Dealers N/A CIK Number 0001756479 Filed Document 0001756479-23-000001 Exclusions or Exemptions 506b Accepted Date 2023-09-22 10:32:04 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
Rhoshan Pharmaceuticals, Inc. See All Filings	D	2019-09-23 16:43:22 UTC
Amount To Be Raised $1,499,994 Associated Brokers / Dealers N/A CIK Number 0001756479 Filed Document 0000905718-19-000783 Exclusions or Exemptions 506b Accepted Date 2019-09-23 16:43:22 UTC Type of Offering D Industry Biotechnology Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
Rhoshan Pharmaceuticals, Inc. See All Filings	D	2018-12-27 08:57:01 UTC
Amount To Be Raised $19,325,000 Associated Brokers / Dealers N/A CIK Number 0001756479 Filed Document 0000905718-18-000991 Exclusions or Exemptions 506b Accepted Date 2018-12-27 08:57:01 UTC Type of Offering D Industry Biotechnology Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity